关注基于临床需求的肺癌病理诊断新进展

Advances of pathological diagnosis of lung cancer based on clinical needs

为满足肿瘤精准治疗时代的临床需求,肺癌的病理诊断也在不断更新和发展,主要体现在肺癌组织学分类的不断更新、用于指导靶向药物治疗的分子检测、免疫治疗相关标志物的检测及新辅助治疗后病理评估方面的进展。新时代肺癌病理诊断体现了临床-影像-病理等多学科诊断模式,正在逐步走向规范化、精准化,以期更好地为临床提供治疗及预后指导。

Pathological diagnosis of lung cancer keep updating and developing,in order to meet the clinical needs in the era of precision medicine.It mainly involves the advances of histological subtype classification,molecular testing for targeted therapy,biomarkers detection for immunotherapy and the pathological evaluation for neoadjuvant therapy.Nowadays,pathological diagnosis of lung cancer present a multidisciplinary model including clinical medicine,radiology and pathology.It is gradually moving towards standardization with expection to provide better guidance for clinical treatment and prognosis.